Seeing Is Believing
Currently out of the existing stock ratings of David Solomon, 7 are a BUY (58.33%), 5 are a HOLD (41.67%).
Analyst David Solomon, currently employed at ROTH MKM, carries an average stock price target met ratio of 100% that have a potential upside of 39.1% achieved within 199 days.
David Solomon’s has documented 23 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on IRIX, IRIDEX at 13-Jan-2021.
Analyst best performing recommendations are on APEN (APOLLO ENDOSURGERY).
The best stock recommendation documented was for APEN (APOLLO ENDOSURGERY) at 11/12/2018. The price target of $3.75 was fulfilled within 1 day with a profit of $0.2 (5.06%) receiving and performance score of 50.63.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 15-May-2024
$2
$0.87 (76.99%)
$3
2 years 5 months 7 days ago
(15-May-2024)
2/2 (100%)
$-0.65 (-24.53%)
220
Buy Since 12-May-2020
$6
$4.65 (344.44%)
5 years 9 months 9 days ago
(13-Jan-2021)
1/1 (100%)
$0.88 (17.19%)
40
What Year was the first public recommendation made by David Solomon?